Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

The first sprayable insecticide made of RNA can target and kill ravenous Colorado potato beetles while sparing most ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Earlier in the week, Novartis said it entered into an agreement with Avidity Biosciences, Inc. (NASDAQ:RNA) to acquire the ...

Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

How do stem cells know what to become? Nearly three decades after scientists isolated the first human embryonic stem cells, researchers are still working hard to understand precisely how a single, ...

Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks ...

Novartis will acquire Avidity Biosciences for $12 billion at $72 per share, gaining its RNA-targeting platform and neuroscience pipeline as Avidity spins off its precision cardiology programs into a ...

Steven Hatfill, a senior biosecurity adviser at the Department of Health and Human Services (HHS), was dismissed after ...

BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...

Fintel reports that on October 28, 2025, RBC Capital downgraded their outlook for Avidity Biosciences (NasdaqGM:RNA) from ...